William G. Richards - Aug 8, 2023 Form 3 Insider Report for 23andMe Holding Co. (ME)

Role
Head of Therapeutics Discovery
Signature
/s/ William Richards, by Kathy Hibbs, attorney-in-fact
Stock symbol
ME
Transactions as of
Aug 8, 2023
Transactions value $
$0
Form type
3
Date filed
8/11/2023, 05:41 PM
Next filing
Aug 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ME Class A Common Stock 219K Aug 8, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ME Stock Option (Right to Buy) Aug 8, 2023 Class A Common Stock 115K $5.04 Direct F1
holding ME Stock Option (Right to Buy) Aug 8, 2023 Class A Common Stock 55K $5.04 Direct F2
holding ME Stock Option (Right to Buy) Aug 8, 2023 Class A Common Stock 30K $8.20 Direct F3
holding ME Stock Option (Right to Buy) Aug 8, 2023 Class A Common Stock 38.8K $12.62 Direct F4
holding ME Stock Option (Right to Buy) Aug 8, 2023 Class A Common Stock 80.5K $3.56 Direct F5
holding ME Stock Option (Right to Buy) Aug 8, 2023 Class A Common Stock 50.6K $2.20 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on March 9, 2021
F2 The stock options vest equally in 1/48 monthly installments beginning on October 1, 2020.
F3 The stock options vest equally in 1/48 monthly installments beginning on May 1, 2021.
F4 The stock options vest equally in 1/48 monthly installments beginning on November 1, 2021.
F5 The stock options vest equally in 1/48 monthly installments beginning on May 1, 2022.
F6 The stock options vest equally in 1/36 monthly installments beginning on May 1, 2023.